Literature DB >> 24742206

Acute kidney injury influences mortality in lung transplantation.

Jing Xue1, Liang Wang, Cai-Mei Chen, Jing-Yu Chen, Zhu-Xing Sun.   

Abstract

OBJECTIVE: To evaluate the association between acute kidney injury (AKI) and long-term survival in lung transplant patients.
METHODS: Clinical data of 88 patients who underwent lung transplantation (LTx) were retrospectively analyzed at our institution from September 2002 to December 2011. Postoperative AKI was defined and divided into three groups based on creatinine criteria from the Acute Kidney Injury Net (AKIN) classification. A multivariable logistic regression model evaluated risk factors for AKI. Primary outcome was 5-year mortality. Risk adjusted multivariable COX proportional hazards regression examined the association of AKI with mortality.
RESULTS: A total of 47 (53.40%) patients developed AKI (27 with AKIN1, 20 with AKIN2-3) in the first week after LTx. Multivariate analysis showed pre-LT (pre-lung transplant) hypertension (OR 1.37 [0.06-2.68], p=0.041) and mechanical ventilation (OR 0.05 [0.01-0.09], p=0.022) were risk factors for postoperative AKI. Five-year survival rates in the non-AKI, AKIN1, and AKIN2-3 groups were 48.8%, 37.0%, 30.0%, respectively (p=0.041). Adjusted for age, sex, type and cause of LT, hypertension and diabetes, the hazard ratio for death was 1.481 ([1.040-2.107]) for AKI.
CONCLUSIONS: The occurrence of AKI after LTx is common. Severe AKI would increase long-term mortality risk. Several variables, including pre-LT hypertension and mechanical ventilation, are associated with AKI after LTx.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24742206     DOI: 10.3109/0886022X.2013.876350

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

2.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

Review 3.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 4.  Acute kidney injury after lung transplantation: a narrative review.

Authors:  Lei Jing; Wenhui Chen; Lijuan Guo; Li Zhao; Chaoyang Liang; Jingyu Chen; Chen Wang
Journal:  Ann Transl Med       Date:  2021-04

5.  Acute Kidney Injury after Lung Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Ploypin Lertjitbanjong; Charat Thongprayoon; Wisit Cheungpasitporn; Oisín A O'Corragain; Narat Srivali; Tarun Bathini; Kanramon Watthanasuntorn; Narothama Reddy Aeddula; Sohail Abdul Salim; Patompong Ungprasert; Erin A Gillaspie; Karn Wijarnpreecha; Michael A Mao; Wisit Kaewput
Journal:  J Clin Med       Date:  2019-10-17       Impact factor: 4.241

6.  Retrospective analysis on incidence and risk factors of early onset acute kidney injury after lung transplantation and its association with mortality.

Authors:  Wen-Wen Du; Xiao-Xing Wang; Dan Zhang; Wen-Qian Chen; Xiang-Lin Zhang; Peng-Mei Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.